Mukofalk Fit (Ispaghula Husk)

Ispaghula Husk, the active ingredient in Mukofalk Fit, is a bulk-forming laxative presented as an oral powder for gastrointestinal use. It is used to relieve constipation, support irritable bowel syndrome management, and may aid in lowering cholesterol levels in adults. GNH USA supplies Mukofalk Fit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Mukofalk Fit, a bulk‑forming laxative, is indicated for conditions affecting bowel regularity and lipid metabolism.

- Constipation: helps normalize stool frequency and consistency by increasing bulk and water content. - Irritable bowel syndrome: alleviates abdominal discomfort and irregular bowel movements through fiber supplementation. - Hypercholesterolemia: contributes to modest reductions in serum cholesterol when used as part of a diet low in saturated fat.

Ispaghula Husk may cause gastrointestinal and allergic reactions, ranging from mild to rare serious events.

Common Side Effects: - Abdominal bloating: feeling of fullness in the abdomen. - Flatulence: increased intestinal gas. - Abdominal cramps: mild, intermittent pain. - Increased stool frequency: more frequent bowel movements. - Mild diarrhea: loose stools without blood. - Nausea: sensation of wanting to vomit.

Serious or Rare Side Effects: - Intestinal obstruction: blockage of the bowel requiring medical attention. - Severe abdominal pain: intense pain that may indicate complications. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Rectal bleeding: presence of blood in stool.

When using Mukofalk Fit, consider the following precautions to ensure safe and effective use.

- Adequate fluid intake: consume at least 8 glasses of water daily to prevent dehydration. - Hydration status: assess patients for existing fluid deficits before initiating therapy. - Bowel obstruction: avoid use in individuals with known or suspected intestinal blockage. - Acute abdominal conditions: do not use during acute abdominal pain or inflammatory bowel disease flare‑ups. - Medication timing: separate administration from drugs that require precise absorption by at least 2 hours. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Ispaghula Husk can affect the absorption of several medicines; interactions vary in clinical significance.

Major Interactions (Avoid): - Mineral oil: co‑administration reduces fiber’s bulking effect and may cause malabsorption. - Antidiarrheal agents (e.g., loperamide): counteract the laxative action of the fiber. - Digoxin: fiber may decrease its absorption, risking sub‑therapeutic levels.

Moderate Interactions (Monitor Closely): - Iron supplements: fiber can bind iron, lowering its bioavailability; separate dosing by 2 hours. - Calcium carbonate: may reduce calcium absorption; stagger administration. - Levothyroxine: potential reduction in absorption; advise spacing doses.